September
August
July
June
May
April
March
February
January
DatabaseOpen Access
Ocular adverse effects of Anti-cancer Chemotherapy
Parul Singh, Abhishek SinghApplied Scientific Reports 2012 1 : 5
( 16 February 2012 )
Original ResearchOpen Access
Cardiovascular comorbidities among patients with metastatic colorectal cancer
Zhongyun Zhao, JA Overbeek, MPP Van Herk-Sukel, BL Barber, RMC HeringsApplied Scientific Reports 2012 1 : 4
( 16 February 2012 )
ReviewOpen Access
Apoptosis , Angiogenesis and Cancer Therapies
Manjul TiwariApplied Scientific Reports 2012 1 : 3
( 16 February 2012 )
HypothesisOpen Access
Epithelial ovarian cancer: A feasible plan for adjunctive treatment using simultaneous acyclovir, ambrisentan, captopril, disulfiram, fluvoxamine-augmented ramelteon, icatibant, imiquimod peritoneal lavage, and plerixafor
Richard KastApplied Scientific Reports 2012 1 : 2
( 16 February 2012 )
Original ResearchOpen Access
Feasibility of cognitive sparing approaches in children with intracranial tumors requiring partial brain radiotherapy: A dosimetric study using tomotherapy
James Marsh, Rohit Godbole, Aidnag Diaz, Arnold Herskovic, Julius TurianApplied Scientific Reports 2012 1 : 1
( 16 February 2012 )
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
Cancer Stem Cells
Journal of Cancer Therapetics & Research Open access Journal covers special section Cancer stem cells aims to publish research on identification, characterization and isolation of cancer stem cells in various cancer types, metastatic mechanisms, surface markers and their role in cancer initiation, progression and maintenance. The scope of the section includes reviews, hypothetical theories, clinical practices and novel techniques in regulating cancer stem cells.
Innovative Therapies
Journal of Cancer Therapetics & Research Open access Journal covers special section Innovative Therapies focuses on the treatment and prevention of cancer. This section inculdes cancer curing therapies and pharmaceutical applications with the study of anti-cancer drugs, therapeutic agents and Drug Development based on the signalling mechanisms and pharmacodynamics.
Carcinogenesis
Journal of Cancer Therapetics & Research Open access Journal contains special section Carcinogenesis covers the study of cells undergoing carcinogenesis with uncontrolled mutagenesis. It includes every aspect of biochemical mechanisms in relation to the cancer development. Also the focus is on medicinal research from diagnostic testing to monitoring of tumor progression through modulating agents and molecular epidemiology, examination of cells and tissues.
Organ Specific Cancers
Journal of Cancer Therapetics & Research Open access Journal covers special section Organ Specific Cancers, With its heterogenetic ability, Cancer has a diversified nature in relation to the organ specificity. This section encompasses study of cancer dvelopment in different organs and their transition among the organs. The primary focus is on heterogeneity, origin, metastasis, angiogenesis and organ specified mechanisms in cancer cells.
Radiation And Imaging
Journal of Cancer Therapetics & Research Open access Journal covers special section Radiation and Imaging section includes medical diagnostic procedures and treatment using radiation, chemotherapy and imaging technology. It focuses on the modified therapeutic strategies to control cancer and implementing preventional methods.
Epidemiology, Genetics And Genomics
Journal of Cancer Therapetics & Research Open access Journal covers special section Epidemiology Genetics and Genomics aim to attract papers in the field of epidemiology, genetics and genomics in cancer cells and cancer patients. Understanding the cancer genetics, gene expression and regulation in cancer cells, their heterogeneity will give new insights in diagnosis and treatment. The section intend to disseminate information and knowledge that may furnish novel applications such as personalized treatment with either DNA or protein kinase targeted drugs, combinations with modern radiotherapeutic approaches. The section also considers studies performing whole genome sequencing to recognize potential drug targets or limited for selected genes to identify patients responding to particular treatments more likely.